OXYGENTA PHARMACEUTICAL
Quarterly Results Analysis [Jun2026]
OXYGENTA PHARMACEUTICAL Quarterly Results
| Standalone | Jun2026 UnAudited |
Mar2026 UnAudited |
Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹37 Cr | ₹50 Cr | ₹34 Cr | ₹14 Cr | ₹15 Cr | ₹49 Cr | ₹34 Cr | ₹15 Cr |
| Expenses | ₹36 Cr | ₹50 Cr | ₹38 Cr | ₹19 Cr | ₹22 Cr | ₹51 Cr | ₹38 Cr | ₹16 Cr |
| Operating Income | ₹1 Cr | ₹0 Cr | ₹-4 Cr | ₹-5 Cr | ₹-7 Cr | ₹-2 Cr | ₹-4 Cr | ₹-1 Cr |
| Other Income | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Interest | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹0 Cr | ₹1 Cr |
| Depreciation | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr |
| Profit Before Tax | ₹-3 Cr | ₹-1 Cr | ₹-6 Cr | ₹-6 Cr | ₹-8 Cr | ₹-4 Cr | ₹-5 Cr | ₹-3 Cr |
| Profit After Tax | ₹-2 Cr | ₹-2 Cr | ₹-5 Cr | ₹-5 Cr | ₹-6 Cr | ₹-2 Cr | ₹-4 Cr | ₹-3 Cr |
| EPS | ₹-0.57 | ₹-0.46 | ₹-1.31 | ₹-1.33 | ₹-1.65 | ₹-0.58 | ₹-1.06 | ₹-0.80 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| OXYGENTA PHARMACEUTICAL | -7.5% | 12.2% | -27% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.7% | -1.4% | 21.7% |
| DIVIS LABORATORIES | 2% | 10.3% | 49.5% |
| TORRENT PHARMACEUTICALS | -0.4% | -0.5% | 38.6% |
| CIPLA | -0.5% | -2.5% | -10.2% |
| DR REDDYS LABORATORIES | -1.2% | 0% | -7.1% |
| MANKIND PHARMA | -1.5% | -3.3% | -4.6% |
| LUPIN | -0.6% | -9.4% | 13% |
| ZYDUS LIFESCIENCES | -3.2% | 2.9% | 19.2% |
OXYGENTA PHARMACEUTICAL Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | -25.43 % |
| Y-o-Y | 144.45 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Jun2026 | ₹37 Cr | -25.43 | |
| Mar2026 | ₹50 Cr | 46.22 | |
| Dec2025 | ₹34 Cr | 138.18 | |
| Sep2025 | ₹14 Cr | -5.87 | |
| Jun2025 | ₹15 Cr | -69.40 | |
| Mar2025 | ₹49 Cr | 46.81 | |
| Dec2024 | ₹34 Cr | 128.36 | |
| Sep2024 | ₹15 Cr | - | |
OXYGENTA PHARMACEUTICAL Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 379.82 % |
| Y-o-Y | Positive |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Jun2026 | ₹1 Cr | 379.82 | |
| Mar2026 | ₹0 Cr | Positive | |
| Dec2025 | ₹-4 Cr | Negative | |
| Sep2025 | ₹-5 Cr | Negative | |
| Jun2025 | ₹-7 Cr | Negative | |
| Mar2025 | ₹-2 Cr | Negative | |
| Dec2024 | ₹-4 Cr | Negative | |
| Sep2024 | ₹-1 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 543.48 % |
| Y-o-Y | Positive |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Jun2026 | 1.48% | 543.48 | |
| Mar2026 | 0.23% | Positive | |
| Dec2025 | -12.01% | Negative | |
| Sep2025 | -32.51% | Negative | |
| Jun2025 | -45.13% | Negative | |
| Mar2025 | -3.95% | Negative | |
| Dec2024 | -11.48% | Negative | |
| Sep2024 | -9.64% | - | |
OXYGENTA PHARMACEUTICAL Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | Negative |
| Y-o-Y | Negative |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Jun2026 | ₹-2 Cr | Negative | |
| Mar2026 | ₹-2 Cr | Negative | |
| Dec2025 | ₹-5 Cr | Negative | |
| Sep2025 | ₹-5 Cr | Negative | |
| Jun2025 | ₹-6 Cr | Negative | |
| Mar2025 | ₹-2 Cr | Negative | |
| Dec2024 | ₹-4 Cr | Negative | |
| Sep2024 | ₹-3 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | Negative |
| Y-o-Y | Negative |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Jun2026 | -5.68 % | Negative | |
| Mar2026 | -3.43 % | Negative | |
| Dec2025 | -14.27 % | Negative | |
| Sep2025 | -34.61 % | Negative | |
| Jun2025 | -40.34 % | Negative | |
| Mar2025 | -4.35 % | Negative | |
| Dec2024 | -11.66 % | Negative | |
| Sep2024 | -19.35 % | - | |
OXYGENTA PHARMACEUTICAL Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | Negative |
| Y-o-Y | Negative |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Jun2026 | ₹-0.57 | Negative | |
| Mar2026 | ₹-0.46 | Negative | |
| Dec2025 | ₹-1.31 | Negative | |
| Sep2025 | ₹-1.33 | Negative | |
| Jun2025 | ₹-1.65 | Negative | |
| Mar2025 | ₹-0.58 | Negative | |
| Dec2024 | ₹-1.06 | Negative | |
| Sep2024 | ₹-0.8 | - | |
You may also like the below Video Courses